99541-23-8

Basic information

• Product Name: b-D-Glucopyranose, 1,6-anhydro-2-azido-4-O-[2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethyl ene)-b-D-glucopyranosyl]-2-deoxy-, 3-acetate
• Synonyms: b-D-Glucopyranose, 1,6-anhydro-2-azido-4-O-[2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethyl ene)-b-D-glucopyranosyl]-2-deoxy-, 3-acetate;3-O-Acetyl-1,6-anhydro-2-azido-2',3'-di-O-benzyl-4',6'-O-benzylidene-2-deoxy-beta-D-cellobiose min. 98%;3-O-Acetyl-2-azido-2',3'-di-O-benzyl-4',6'-O-benzylidene-2-deoxy-cellobiosan;1,6-Anhydro-2-azido-4-O-[2,3-bis-O-(phenylmethyl)-4,6-O-(phenylmethylene)-beta-D-glucopyranosyl]-2-deoxy-beta-D-glucopyranose 3-acetate;3-O-Acetyl-1,6-anhydro-2-azido-2',3'-di-O-benzyl-4',6'-O-benzylidene-2-deoxy-b-D-cellobiose
• CAS NO: 99541-23-8
• Molecular Formula: C₃₅H₃₇N₃O₁₀
• EINECS: -0
• Mol File: 99541-23-8.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: b-D-Glucopyranose, 1,6-anhydro-2-azido-4-O-[2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethyl ene)-b-D-glucopyranosyl]-2-deoxy-, 3-acetate(CAS DataBase Reference)
• NIST Chemistry Reference: b-D-Glucopyranose, 1,6-anhydro-2-azido-4-O-[2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethyl ene)-b-D-glucopyranosyl]-2-deoxy-, 3-acetate(99541-23-8)
• EPA Substance Registry System: b-D-Glucopyranose, 1,6-anhydro-2-azido-4-O-[2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethyl ene)-b-D-glucopyranosyl]-2-deoxy-, 3-acetate(99541-23-8)

Safety Data

• Hazardous Substances Data: 99541-23-8(Hazardous Substances Data)

Upstream product

• 99571-46-7 2',3'-di-O-benzyl derivative of 1,6-anhydro-4',6'-O-benzylidenecellobiose 
• 99541-22-7 O-(2,3-di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranosyl)-(1->4)-1,6:2,3-dianhydro-β-D-mannopyranose 
• 108-24-7 acetic anhydride 
• 135415-93-9 (1R,2S,3R,4R,5R)-4-Azido-2-((4aR,6S,7R,8S,8aR)-7,8-bis-benzyloxy-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-6-yloxy)-6,8-dioxa-bicyclo[3.2.1]octan-3-ol 

Downstream Products

• 1374030-67-7 6-O-acetyl-2-azido-2-deoxy-3,4-di-O-benzyl-α-D-glucopyranosyl-(1→4)-O-[benzyl 2,3-O-dibenzyl-β-D-glucopyranosyluronate]-(1→4)-O-2-azido-2-deoxy-3,6-di-O-acetyl-1-O-trichloroacetimidoyl-β-D-glucopyranose 
• 1374030-65-5 6-O-acetyl-2-azido-2-deoxy-3,4-di-O-benzyl-α-D-glucopyranosyl-(1→4)-O-[benzyl 2,3-O-dibenzyl-β-D-glucopyranosyluronate]-(1→4)-O-2-azido-2-deoxy-3,6-di-O-acetyl-β-D-glucopyranose 
• 1374030-63-3 6-O-acetyl-2-azido-2-deoxy-3,4-di-O-benzyl-α-D-glucopyranosyl-(1→4)-O-[benzyl 2,3-O-dibenzyl-β-D-glucopyranosyluronate]-(1→4)-O-2-azido-2-deoxy-1,3,6-tri-O-acetyl-β-D-glucopyranose 
• 1374030-61-1 EDC-Trimer-CB 
• 1374030-56-4 Benzylester-Anhydro-Cellobiose DCBB 
• 99541-27-2 O-(6-O-acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-α-D-glucopyranosyl)-(1->4)-O-(methyl 2,3-di-O-benzyl-β-D-glucopyranosyluronate)-(1->4)-3-O-acetyl-1,6-anhydro-2-azido-2-deoxy-β-D-glucopyranose 
• 100752-65-6 O-(2-azido-3,4-di-O-benzyl-2-deoxy-α-D-glucopyranosyl)-(1->4)-O-(methyl 2,3-di-O-benzyl-β-D-glucopyranosyluronate)-(1->4)-1,6-anhydro-2-azido-2-deoxy-β-D-glucopyranose 
• 100752-72-5 (2S,3S,4S,5R,6R)-3-((2R,3R,4R,5S,6R)-3-Azido-4,5-bis-benzyloxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-6-((1R,2S,3R,4R,5R)-4-azido-3-hydroxy-6,8-dioxa-bicyclo[3.2.1]oct-2-yloxy)-4,5-bis-benzyloxy-tetrahydro-pyran-2-carboxylic acid 
• 99541-25-0 O-(2,3-di-O-benzyl-4-O-(chloroacetyl)-6-O-trityl-β-D-glucopyranosyl)-(1->4)-3-O-acetyl-1,6-anhydro-2-azido-2-deoxy-β-D-glucopyranose 
• 100752-71-4 (2S,3S,4S,5R,6R)-6-((1R,2S,3R,4R,5R)-3-Acetoxy-4-azido-6,8-dioxa-bicyclo[3.2.1]oct-2-yloxy)-4,5-bis-benzyloxy-3-(2-chloro-acetoxy)-tetrahydro-pyran-2-carboxylic acid 
• 99541-26-1 O-(methyl 2,3-di-O-benzyl-β-D-glucopyranosyluronate)-(1->4)-3-O-acetyl-1,6-anhydro-2-azido-2-deoxy-β-D-glucopyranose 
• 87907-02-6 O-(methyl 2,3-di-O-benzyl-4-O-(chloroacetyl)-β-D-glucopyranosyluronate)-(1->4)-3-O-acetyl-1,6-anhydro-2-azido-2-deoxy-β-D-glucopyranose 
• 99541-24-9 O-(2,3-di-O-benzyl-β-D-glucopyranosyl)-(1->4)-3-O-acetyl-1,6-anhydro-2-azido-2-deoxy-β-D-glucopyranose 

Relevant articles and documents

AN EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM

The present invention relates to a process for the synthesis of the Factor Xa anticoagulent Fondaparinux and related compounds. The invention relates, in addition, to efficient and scalable processes for the synthesis of various intermediates useful in the synthesis of Fondaparinux and related compounds.